![]() |
Trials |
Potentially Resectable Metastatic Colorectal Cancer With Wild-type KRAS and BRAF: Alternating Chemotherapy Plus Cetuximab - A Randomised Phase II TrialCancer type: Colorectal cancer Phase: II Principal Investigator: Sørbye Halfdan Country: NO Keywords: Norway, Bergen Status: Inclusion completed Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01867697 |